This issue of Immunology and Allergy Clinics, guest edited by Mariana Castells, is devoted to Drug Hypersensitivity and Desensitizations. Articles in this issue include: Principles and Practice of Drug Desensitization; Incidence and Prevalence of Drug Hypersensitivity; Drug-Induced Anaphylaxis; Penicillin and Beta Lactam Hypersensitivity; Platins Chemotherapy Hypersensitivity: Prevalence and Management; Monoclonal Antibodies Hypersensitivity: Prevalence and Management; Injectable Drugs and MoAbs Reactions and Management with Desensitization; Delayed Cutaneous Reactions to Antibiotics, Management with Desensitization; Management of Children with Hypersensitivity to Antibiotics and MoAbs; Taxenes Hypersensitivity and Management; Progesterone Autoimmune Dermatitis; Severe Delayed Drug Reaction: Role of Genetics and Viral Infections; andAspirin and NSAIDS Hypersensitivity and Management.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. The Clinical Evaluation of Angioedema - p. 449 10. Histaminergic Angioedema - p. 467 11. Angiotensin-converting Enzyme Inhibitor and Other Drug-associated Angioedema - p. 483 12. Acquired C1 Inhibitor Deficiency - p. 497 13. Pathogenesis of Hereditary Angioedema: The Role of the Bradykinin-Forming Cascade - p. 513 14. Laboratory Approaches for Assessing Contact System Activation - p. 527 15. Acute Management of Hereditary Angioedema Attacks - p. 541 16. Prophylactic Therapy for Hereditary Angioedema - p. 557 17. Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment - p. 571 18. Emerging Therapies in Hereditary Angioedema - p. 585 19. Burden of Illness and Quality-of-Life Measures in Angioedema Conditions - p. 597 20. Pharmacoeconomics of Orphan Disease Treatment with a Focus on Hereditary Angioedema - p. 617
This issue of Immunology and Allergy Clinics, guest edited by Mariana Castells, is devoted to Drug Hypersensitivity and Desensitizations. Articles in this issue include: Principles and Practice of Drug Desensitization; Incidence and Prevalence of Drug Hypersensitivity; Drug-Induced Anaphylaxis; Penicillin and Beta Lactam Hypersensitivity; Platins Chemotherapy Hypersensitivity: Prevalence and Management; Monoclonal Antibodies Hypersensitivity: Prevalence and Management; Injectable Drugs and MoAbs Reactions and Management with Desensitization; Delayed Cutaneous Reactions to Antibiotics, Management with Desensitization; Management of Children with Hypersensitivity to Antibiotics and MoAbs; Taxenes Hypersensitivity and Management; Progesterone Autoimmune Dermatitis; Severe Delayed Drug Reaction: Role of Genetics and Viral Infections; andAspirin and NSAIDS Hypersensitivity and Management.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. The Clinical Evaluation of Angioedema - p. 449 10. Histaminergic Angioedema - p. 467 11. Angiotensin-converting Enzyme Inhibitor and Other Drug-associated Angioedema - p. 483 12. Acquired C1 Inhibitor Deficiency - p. 497 13. Pathogenesis of Hereditary Angioedema: The Role of the Bradykinin-Forming Cascade - p. 513 14. Laboratory Approaches for Assessing Contact System Activation - p. 527 15. Acute Management of Hereditary Angioedema Attacks - p. 541 16. Prophylactic Therapy for Hereditary Angioedema - p. 557 17. Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment - p. 571 18. Emerging Therapies in Hereditary Angioedema - p. 585 19. Burden of Illness and Quality-of-Life Measures in Angioedema Conditions - p. 597 20. Pharmacoeconomics of Orphan Disease Treatment with a Focus on Hereditary Angioedema - p. 617
